News

NORD, EURORDIS, and Rare Disease Organizations in 30 Nations Announce an International Rare Diseases Alliance (copy 1)


 

References

The leading rare disease patient organizations in the US and Europe—NORD and EURORDIS—together with rare disease umbrella organizations from 30 nations around the world have launched a new global alliance to be known as Rare Diseases International. The collaboration was announced May 28th at a meeting in Madrid. NORD will be the US representative in this alliance, which also adopted a joint declaration for rare diseases to be an international public health priority. Read the press release.

Recommended Reading

Panel calls for screening for patients with Fanconi anemia
MDedge Endocrinology
New tool facilitates clinical trial follow-up
MDedge Endocrinology
Genetics information for health professionals who are not genetics specialists
MDedge Endocrinology
Controversial technique appeals to women with mitochondrial diseases
MDedge Endocrinology
NORD to honor NIH Director and others at Portraits of Courage Celebration
MDedge Endocrinology
NORD urges Congress to support development of treatments for rare pediatric diseases
MDedge Endocrinology
How to code for cystic fibrosis–related diabetes
MDedge Endocrinology
Cystic fibrosis–related diabetes requires different approach
MDedge Endocrinology
ILC: NAFLD a stealth trigger of hepatocellular carcinoma
MDedge Endocrinology
ASA: Mutation testing aids decision making in thyroid cancer
MDedge Endocrinology